Patents by Inventor Lars Bode

Lars Bode has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11896603
    Abstract: The disclosure provides for the use of an oligosaccharide for the treatment of liver disease. More particularly, the disclosure provide methods and composition for treating liver disease comprising administering 2?-FL to a subject.
    Type: Grant
    Filed: June 11, 2021
    Date of Patent: February 13, 2024
    Assignee: The Regents of the University of California
    Inventors: Lars Bode, Bernd Schnabl
  • Publication number: 20230201228
    Abstract: The disclosure provides for immunomodulatory oligosaccharides, and uses thereof.
    Type: Application
    Filed: February 17, 2023
    Publication date: June 29, 2023
    Inventors: Lars Bode, Philip Gordts
  • Publication number: 20230181609
    Abstract: The disclosure provides for immunomodulatory oligosaccharides, and uses thereof.
    Type: Application
    Filed: February 9, 2023
    Publication date: June 15, 2023
    Inventors: Lars Bode, Philip Gordts
  • Publication number: 20230149433
    Abstract: The disclosure provides for immunomodulatory oligosaccharides, and uses thereof.
    Type: Application
    Filed: January 23, 2023
    Publication date: May 18, 2023
    Inventors: Lars Bode, Philip Gordts
  • Publication number: 20220143056
    Abstract: The disclosure provides for therapies and methods to treat atherosclerosis and/or hyperlipidemia, and complications resulting therefrom, with compositions that comprise therapeutically effective amounts of one or more human milk oligosaccharides.
    Type: Application
    Filed: January 25, 2022
    Publication date: May 12, 2022
    Inventors: Philip Gordts, Ariane Pessentheiner, Lars Bode
  • Patent number: 11234992
    Abstract: The disclosure provides for therapies and methods to treat atherosclerosis and/or hyperlipidemia, and complications resulting therefrom, with compositions that comprise therapeutically effective amounts of one or more human milk oligosaccharides.
    Type: Grant
    Filed: February 28, 2019
    Date of Patent: February 1, 2022
    Assignee: The Regents of the University of California
    Inventors: Philip Gordts, Ariane Pessentheiner, Lars Bode
  • Publication number: 20210386765
    Abstract: The disclosure provides for the use of an oligosaccharide for the treatment of liver disease. More particularly, the disclosure provide methods and composition for treating liver disease comprising administering 2?-FL to a subject.
    Type: Application
    Filed: June 11, 2021
    Publication date: December 16, 2021
    Inventors: Lars Bode, Bernd Schnabl
  • Publication number: 20210236527
    Abstract: The disclosure provides for immunomodulatory oligosaccharides, and uses thereof.
    Type: Application
    Filed: April 15, 2021
    Publication date: August 5, 2021
    Inventors: Lars Bode, Philip Gordts
  • Publication number: 20210236526
    Abstract: The disclosure provides for immunomodulatory oligosaccharides, and uses thereof.
    Type: Application
    Filed: April 15, 2021
    Publication date: August 5, 2021
    Applicant: The Regents of the University of California
    Inventors: Lars Bode, Philip Gordts
  • Patent number: 10987718
    Abstract: The present invention concerns a method for production of a supporting member with an at least partially closed cross-section, having at least a first metal shell and a second metal shell which are connected together at least in portions in the longitudinal direction. The method includes a provision of at least a first and a second metal blank. At least a first and a second metal shell are produced from the respective first and second metal blanks. The first and second metal shells each have at least one floor with two protruding uprights spaced apart from each other and integrally connected to the floor. The first and second metal shells are positioned such that the uprights of the metal shells come into overlapping contact.
    Type: Grant
    Filed: June 18, 2019
    Date of Patent: April 27, 2021
    Assignees: ThyssenKrupp Steel Europe AG, thyssenkrupp AG
    Inventors: Martin Kibben, Thomas Flehmig, Daniel Nierhoff, Lars Bode
  • Publication number: 20200237793
    Abstract: The disclosure provides for immunomodulatory oligosaccharides, and uses thereof.
    Type: Application
    Filed: April 3, 2020
    Publication date: July 30, 2020
    Applicant: The Regents of the University of California
    Inventors: Lars Bode, Philip Gordts
  • Publication number: 20200230161
    Abstract: The disclosure provides for immunomodulatory oligosaccharides, and uses thereof.
    Type: Application
    Filed: April 3, 2020
    Publication date: July 23, 2020
    Applicant: The Regents of the University of California
    Inventors: Lars Bode, Philip Gordts
  • Publication number: 20190388953
    Abstract: The present invention concerns a method for production of a supporting member with an at least partially closed cross-section, having at least a first metal shell and a second metal shell which are connected together at least in portions in the longitudinal direction. The method includes a provision of at least a first and a second metal blank. At least a first and a second metal shell are produced from the respective first and second metal blanks. The first and second metal shells each have at least one floor with two protruding uprights spaced apart from each other and integrally connected to the floor. The first and second metal shells are positioned such that the uprights of the metal shells come into overlapping contact.
    Type: Application
    Filed: June 18, 2019
    Publication date: December 26, 2019
    Applicants: ThyssenKrupp Steel Europe AG, thyssenkrupp AG
    Inventors: Martin Kibben, Thomas Flehmig, Daniel Nierhoff, Lars Bode
  • Publication number: 20190269713
    Abstract: The disclosure provides for therapies and methods to treat atherosclerosis and/or hyperlipidemia, and complications resulting therefrom, with compositions that comprise therapeutically effective amounts of one or more human milk oligosaccharides.
    Type: Application
    Filed: February 28, 2019
    Publication date: September 5, 2019
    Inventors: Philip Gordts, Ariane Pessentheiner, Lars Bode
  • Patent number: 10315389
    Abstract: The disclosure relates to a blank-shaped or strip-shaped semi-finished product comprising at least one first metal layer and at least one plastics layer, which are joined over their full area to one another to form a metal/plastic composite. The material thickness of the metal layer is not more than 1.5 mm. The material thickness of the plastics layer is at least 0.2 mm. A method for producing said product is also provided. One object of the present invention, of providing a semi-finished product which is significantly lighter than the semi-finished products used in the prior art, is achieved for a semi-finished product.
    Type: Grant
    Filed: November 3, 2015
    Date of Patent: June 11, 2019
    Assignees: ThyssenKrupp Steel Europe AG, thyssenkrupp AG
    Inventors: Lars Bode, Ralf Sünkel
  • Patent number: 10160986
    Abstract: The present invention provides a one-pot multi-enzyme method for preparing UDP-sugars from simple sugar starting materials. The invention also provides a one-pot multi-enzyme method for preparing oligosaccharides from simple sugar starting materials.
    Type: Grant
    Filed: February 5, 2016
    Date of Patent: December 25, 2018
    Assignee: The Regents of the University of California
    Inventors: Xi Chen, Hai Yu, Yanhong Li, Yi Chen, Jingyao Qu, Musleh M. Muthana, Kam Lau, Lars Bode
  • Publication number: 20180134008
    Abstract: A strip-shaped, plate-shaped, or sheet-shaped semi-finished product may include a particle-reinforced steel material. The particle-reinforced steel material may be connected integrally and over an entire surface area on one or both sides to at least one layer comprised of a non-particle-reinforced metal material. The at least one layer may have a thickness of between 0.2% and 20% of an overall thickness of the semi-finished product and, in some cases, between 0.5% and 15%. The non-particle-reinforced metal material may comprise steel, structural steel, or high-grade steel, for instance. Further, the semi-finished product may be produced by way of cladding or casting.
    Type: Application
    Filed: February 26, 2016
    Publication date: May 17, 2018
    Applicants: THYSSENKRUPP STEEL EUROPE AG, thyssenkrupp AG
    Inventors: Lars BODE, Ralf SÜNKEL
  • Publication number: 20170341343
    Abstract: The disclosure relates to a blank-shaped or strip-shaped semi-finished product comprising at least one first metal layer and at least one plastics layer, which are joined over their full area to one another to form a metal/plastic composite. The material thickness of the metal layer being is not more than 1.5 mm. The material thickness of the plastics layer is at least 0.2 mm. A method for producing said product is also provided. One object of the present invention, of providing a semi-finished product which is significantly lighter than the semi-finished products used in the prior art, is achieved for a semi-finished product.
    Type: Application
    Filed: November 3, 2015
    Publication date: November 30, 2017
    Applicants: ThyssenKrupp Steel Europe AG, ThyssenKrupp AG
    Inventors: Lars BODE, Ralf SUNKEL
  • Publication number: 20170204444
    Abstract: The present invention provides a one-pot multi-enzyme method for preparing UDP-sugars from simple sugar starting materials. The invention also provides a one-pot multi-enzyme method for preparing oligosaccharides from simple sugar starting materials.
    Type: Application
    Filed: February 5, 2016
    Publication date: July 20, 2017
    Applicant: The Regents of the University of California
    Inventors: Xi Chen, Hai Yu, Yanhong Li, Yi Chen, Jingyao Qu, Musleh M. Muthana, Kam Lau, Lars Bode
  • Patent number: 9675649
    Abstract: The invention provides formulations comprising isolated Disialyllacto-N-tetraose (DSLNT) or variants, isomers, analogs and derivatives thereof.
    Type: Grant
    Filed: February 3, 2012
    Date of Patent: June 13, 2017
    Assignee: The Regents of the University of California
    Inventor: Lars Bode